Sub menu

 
 

Australian prescription medicine decision summaries

These decision summaries provide an overview of our evaluation process leading to the registration of a new prescription medicine.

For more information please visit the Australian prescription medicine decision summaries information page. 

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

Published date

225 result(s) found, displaying 126 to 150

  • Illuccix

    Prescription medicine decision summary
    TGA decision: Illuccix (Glu-urea-Lys(ahx)-hbed-CC) is a radioactive diagnostic agent used to assist in the treatment of prostate cancer.

  • Truseltiq

    Prescription medicine decision summary
    TGA decision: Truseltiq (infigratinib) is approved to treat cholangiocarcinoma.

  • Bevacip/Bevaciptin

    Prescription medicine decision summary
    TGA decision: Bevacip/Bevaciptin (bevacizumab) is approved to treat various types of cancers.

  • VeraSeal

    Prescription medicine decision summary
    TGA decision: VeraSeal (human fibrinogen/ human thrombin) is approved to treat hemostasis.

  • Brukinsa

    Prescription medicine decision summary
    Australian prescription medicine decision summary

  • Enhertu

    Prescription medicine decision summary
    Australian prescription medicine decision summary

  • Ronapreve

    Prescription medicine decision summary
    Australian prescription medicine decision summary

  • Brukinsa

    Prescription medicine decision summary
    Australian prescription medicine decision summary

  • Cuprior

    Prescription medicine decision summary
    Australian prescription medicine decision summary

  • Ruzurgi

    Prescription medicine decision summary
    Australian prescription medicine decision summary

  • Leqvio

    Prescription medicine decision summary
    Australian prescription medicine decision summary

  • Zepzelca

    Prescription medicine decision summary
    Australian prescription medicine decision summary

  • Crysvita

    Prescription medicine decision summary
    Australian prescription medicine decision summary

  • Abevmy

    Prescription medicine decision summary
    Australian prescription medicine decision summary

  • Trodelvy

    Prescription medicine decision summary
    Australian prescription medicine decision summary

  • Reblozyl

    Prescription medicine decision summary
    Australian prescription medicine decision summary

  • Kamrab

    Prescription medicine decision summary
    Australian prescription medicine decision summary

  • Xevudy

    Prescription medicine decision summary
    Australian prescription medicine decision summary

  • Spikevax

    Prescription medicine decision summary
    Australian prescription medicine decision summary

  • Dayvigo

    Prescription medicine decision summary
    Australian prescription medicine decision summary

  • Palynziq

    Prescription medicine decision summary
    Australian prescription medicine decision summary

  • Rukobia

    Prescription medicine decision summary
    Australian prescription medicine decision summary

  • Ledaga

    Prescription medicine decision summary
    Australian prescription medicine decision summary

  • COVID-19 Vaccine Janssen

    Prescription medicine decision summary
    Australian prescription medicine decision summary

  • Vyepti

    Prescription medicine decision summary
    Australian prescription medicine decision summary

Help us improve the Therapeutic Goods Administration site